Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, and Lymphoma Diagnosis and Treatment.
In memoriam Prof. Dr. Werner Grote (1938–2025)
Altered enhancer-promoter interaction leads to <i>MNX1</i> expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13).
An artificial intelligence-assisted clinical framework to facilitate diagnostics and translational discovery in hematologic neoplasia
Altered enhancer-promoter interaction leads to <i>MNX1</i> expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)
S120: MNX1-ACTIVATING ENHANCER HIJACKING EVENTS IN ACUTE MYELOID LEUKEMIA WITH DELETIONS ON CHROMOSOME 7Q
Guiding the global evolution of cytogenetic testing for hematologic malignancies
Guiding the global evolution of cytogenetic testing for hematologic malignancies.
Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases
Validation and clinical application of transactivation assays for RUNX1 variant classification.
Fla-IDA Chemotherapy with or without Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
Germline variants drive myelodysplastic syndrome in young adults
The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia
Association of unbalanced translocation der(1;7) with germline GATA2 mutations
Association of unbalanced translocation der(1;7) with germline GATA2 mutations.
Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies.
Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence
SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome.
Publisher Correction: Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
High-risk additional chromosomal abnormalities at low blast counts herald death by CML
Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper
IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction—a retrospective propensity score analysis
Knockout of the HMG domain of the porcine SRY gene causes sex reversal in gene-edited pigs
Implementation of RNA sequencing and array CGH in the diagnostic workflow of the AIEOP-BFM ALL 2017 trial on acute lymphoblastic leukemia
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols
Breast cancer risk in <i>BRCA1/2</i> mutation carriers and noncarriers under prospective intensified surveillance
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations
Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma